LINC00205 Promotes Tumor Malignancy of Lung Adenocarcinoma Through Sponging miR-185-5p

Author:

Li Yongqiang1,Hu Yahui2,Wu Yuting1,Zhang Deming2,Huang Dongwei2

Affiliation:

1. Department of Respiratory Medicine, PLA General Hospital of Southern Theatre Command, Guangzhou, Guangdong, China

2. Department of Geriatric Respiratory Medicine, PLA General Hospital of Southern Theatre Command, Guangzhou, Guangdong, China

Abstract

Abstract The emerging role of long noncoding RNAs (lncRNAs) in cancer, especially in lung adenocarcinoma (LUAD), is attracting increasingly more attention as a potential therapeutic target. However, whether lncRNA LINC00205 regulates the malignancy of LUAD has not been characterized. In this study, we discovered that LINC00205 was markedly upregulated in LUAD tissues and cell lines and correlated with poor prognosis of patients with LUAD. Our data showed that LINC00205 promoted the migration and proliferation of LUAD cells in vitro and tumor growth in vivo. Notably, the tumor suppressor miR-185-5p was found to be a direct target of LINC00205. In addition, miR-185-5p diminished the promotion of cell proliferation and migration mediated by LINC00205, whereas miR-185-5p inhibition had the opposite effect. In summary, our results show that LINC00205 contributes to LUAD malignancy by sponging miR-185-5p, which provides new insight into LUAD progression.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Reference37 articles.

1. Global cancer statistics;Jemal;CA A Cancer J Clin,2011

2. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers;Välk;Oncology,2010

3. World Health Organization classification of tumours, pathology and genetics of tumours of the lung;Teng;Zhonghua Bing Li Xue Za Zhi.,2005

4. Histologic subtype in NSCLC: does it matter?;Selvaggi;Oncology (Williston Park).,2009

5. Molecular targeted agents and biologic therapies for non-small cell lung cancer;Somaiah;J Thoracic Oncol.,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3